News summary

Abc biopply and VoxCell partner on vascularized tissue models

Source: Swiss Biotech • Published: 08 Oct 2026, 00:00

Summarized by Masters of Longevity from Swiss Biotech.

Vascularized organoid model collaboration: preview an industry partnership building integrated human tissue platforms to enhance preclinical predictive power.

Abc biopply and VoxCell partner on vascularized tissue models
Key Takeaways
  • Abc biopply will integrate VoxCell's perfused, endothelial-lined vasculature into its 3D CoSeedis humanized organoid service offerings.
  • The partnership targets New Approach Methodologies to improve translational relevance and reduce reliance on animal models.
  • Both companies plan longer-term joint technology development to create vascularized multi-organoid systems for IND-relevant testing.
Read the full article at Swiss Biotech ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.